CORONA Remedies Limited (CORONA) — Financial Results | 22 July 2026
CORONA Remedies Limited announced its Q1 FY27 earnings conference call scheduled for August 3, 2026 at 11:30 a.m. IST to discuss financial results for the quarter ended June 30, 2026, with management representation including the Managing Director, Joint Managing Director, and CFO.
About CORONA Remedies Limited (CORONA)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when CORONA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track CORONA — Free💡 Ask AI about this filing
📊 More CORONA filings
- Announcement — 28 September 2026Corona Remedies Ltd announced that its trading window will close on October 1, 2026, remaining shut ...
- 🔴 Insider Trading — 19 September 2026Sepia Investments Limited, Sage Investment Trust, and Anchor Partners sold 2,485,476; 51,641; and 92...
- 🔴 Insider Trading — 19 September 2026Sepia Investments Limited, Sage Investment Trust and Anchor Partners sold a combined 2,630,880 share...
- 🔴 Announcement — 18 September 2026Corona Remedies Ltd announced an analyst and investor meeting scheduled for September 23, 2026 at 2:...
- Announcement — 10 September 2026Corona Remedies clarified that recent share volume increases are purely market-driven with no undisc...
🔥 Also filed on 22 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when CORONA files new disclosures
Track CORONA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CORONA — FreeFree account · 2 AI queries/day